Sleep Cycle AB

As of June 30, 2026, Sleep Cycle AB carries a market capitalization of 497.81M, placing it among publicly traded companies globally. Its enterprise value stands at 404.54M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sleep Cycle AB's next confirmed earnings release is scheduled for October 23, 2026.

As of June 30, 2026, Sleep Cycle AB has 20.28M shares outstanding.

As of June 30, 2026, Sleep Cycle AB trades at a trailing price-to-earnings ratio of 19.59. The price-to-sales ratio is 2.36, and the price-to-book ratio stands at 8.21.

As of June 30, 2026, Sleep Cycle AB trades at an EV/EBITDA multiple of 10.82 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.91 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.94 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Sleep Cycle AB trades at an EV/FCF ratio of 8.85, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 404.54M versus a market cap of 497.81M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Sleep Cycle AB maintains a current ratio of 1.14, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.58, indicating elevated leverage, while an interest coverage ratio of 107.41 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Sleep Cycle AB posted a return on equity (ROE) of 33.04, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 29.16 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 11.34, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 30.34, useful for judging operating efficiency across full business cycles. The company generates approximately 5.15M in revenue per employee across its workforce of 41.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Sleep Cycle AB recorded 6.78M in income tax expense. That works out to an effective tax rate of 21.05, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 32.20M, leaving 25.42M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Sleep Cycle AB's stock has declined approximately 7.46% over the past 52 weeks. The 50-day moving average sits at 22.76, while the 200-day moving average is 21.60.

Over the twelve months ended June 30, 2026, Sleep Cycle AB generated 211.27M in revenue and converted that into 25.42M in net income, yielding earnings per share of 1.25. EBITDA reached 37.38M, while operating income came in at 31.27M.

As of June 30, 2026, Sleep Cycle AB holds 99.09M in cash and equivalents against 5.81M in total debt, resulting in a net debt position of -99.09M. Total book value stands at 60.64M, with working capital of 17.88M providing operational flexibility.

Sleep Cycle AB produced 45.49M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -48,000.00 in capital expenditures, free cash flow totaled 45.44M - equivalent to 2.24 per share.

Over the twelve months ended June 30, 2026, Sleep Cycle AB posted a gross margin of 62.22, reflecting its pricing power and cost economics. The operating margin of 14.80 and net profit margin of 12.03 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Sleep Cycle AB paid dividends of 3.53 per share. The dividend payout ratio of 281.60 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 9.13, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 15.00, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Sleep Cycle AB shareholders.

As of June 30, 2026, Sleep Cycle AB has an Altman Z-Score of 4.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.